Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Where Your Profits Grow Sky High.

Johannes Kepler University of Linz: Injection against heart attacks

David Bernhard © JKU

Taking action quickly can help to save lives. Researchers at the Johannes Kepler University of Linz are now developing an injection with which emergency physicians can save about 20 percent of the patient’s heart muscle from dying off. The new drug has already been successfully tested in the laboratory.

In the case of a heart attack, part of the heart is cut off from the oxygen supply. The surrounding heart tissue is not fully supplied with ultimately first ties after some time. This issue can be saved thanks to the new development of Prof. David Bernhard, Head of the Center for Medical Research at Johannes Kepler University of Linz. He developed a substance named 5`-Methoxyleoligin. The special property of this substance is that it not only protects the insufficiently supplied heart issue from the effects of the heart attack but can also be administered intravenously. Up until now treatment of the heart could first take place in a hospital within the context of a surgical procedure. Methoxyleoligin is originally derived from the roots of the edelweiss but can be synthetically produced in the meantime. All in all, experts from six Austrian universities worked on the project for several years under the leadership of the University of Linz.

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • Üzlet Ausztriában konzultációs nap

    18.09.2019 / 14:00 - 17:00, Debrecen, Hungary

Austria Map

Find the perfect location for your company

The new Amazon distribution center in Großebersdorf is our first logistics site in Austria It will enable us to create additional and more flexible delivery capacities for the benefit of customers. We feel that we are in good hands, also thanks to the support of ABA – Invest in Austria.

Amazon

amazon.de
More testimonials

news from the business location Austria

Pfizer builds international quality control centre in Austria

A total of EUR 50 million is being invested in the construction of a new laboratory for an international quality control centre for vaccines, as well as the construction of modern office space and the modernisation and expansion of the existing infrastructure for vaccine production.

Austrian SMEs Implement Measures to Curb Climate Change

Drought, storms, floods and mass immigration: climate change is real, and its consequences will pose massive challenges to society, political decision makers and the economy. This text focuses on how Austrian SMEs face the effects of climate change and why the changes also open up economic opportunities.

More news All blog posts